COVIDVu
COVIDVu is national serosurvey for SARS-CoV-2 PCR positivity and immune experience. A probability sample of U.S. addresses were mailed invitations and kits for the self-collection of anterior nares swab and finger prick dried blood spot specimens.
Publications
-
Cumulative Incidence of SARS-CoV-2 Infections Among Adults in Georgia, United States, August to December 2020
-
Nationally Representative Social Contact Patterns among U.S. Adults, August 2020-April 2021
-
Protocol for a national probability survey using home specimen collection methods to assess prevalence and incidence of SARS-CoV-2 infection and antibody response
-
SARS-CoV-2 Cumulative Incidence and Period Seroprevalence: Results From a Statewide Population-Based Serosurvey in California
-
Severe Acute Respiratory Syndrome Coronavirus 2 Cumulative Incidence, United States, August 2020–December 2020
-
Trajectory of COVID-19 Vaccine Hesitancy Over Time and Association of Initial Vaccine Hesitancy With Subsequent Vaccination
-
Use of COVIDTests.gov At-Home Test Kits Among Adults in a National Household Probability Sample — United States, 2022